This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Areschoug, T.
Right arrow Articles by Lindahl, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Areschoug, T.
Right arrow Articles by Lindahl, G.

 Previous Article  |  Next Article 

Infection and Immunity, December 1999, p. 6350-6357, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Group B Streptococcal Surface Proteins as Targets for Protective Antibodies: Identification of Two Novel Proteins in Strains of Serotype V

Thomas Areschoug, Margaretha Stålhammar-Carlemalm, Charlotte Larsson, and Gunnar Lindahl*

Department of Laboratory Medicine, Lund University, S-22362 Lund, Sweden

Received 2 August 1999/Returned for modification 20 September 1999/Accepted 30 September 1999

Strains of group B streptococcus (GBS) express surface proteins that confer protective immunity. In particular, most strains of the four classical capsular serotypes (Ia, Ib, II, and III) express either of the Rib and alpha  proteins, two members of the same protein family. Here, we report a study of surface proteins expressed by strains of serotype V, which has recently emerged as an important serotype among GBS strains causing serious disease. Two novel GBS proteins were identified, purified, and characterized. One of these proteins, designated Fbs, was immunologically unrelated to other GBS surface proteins. This ~110-kDa protein was found in 15 of 49 (31%) type V isolates but in few strains of other serotypes. The Fbs proteins expressed by different strains showed limited variation in size. The most common surface protein among type V strains, found in 29 of 49 (59%) isolates, was designated Rib-like, since it cross-reacted with Rib but was not immunologically identical to Rib. Characterization of this Rib-like protein showed that the N-terminal sequence (12 residues) was identical to that of alpha , although these two proteins lacked cross-reactivity. The biochemical and immunological properties of the Rib-like GBS protein indicate that it is closely related to the R28 protein of Streptococcus pyogenes. Importantly, passive and active immunization experiments with mice showed that the Fbs and Rib-like proteins are targets for protective antibodies. These two proteins are therefore of interest for analysis of pathogenic mechanisms and for vaccine development.


* Corresponding author. Mailing address: Department of Laboratory Medicine, Lund University, Sölvegatan 23, S-22362 Lund, Sweden. Phone: 46-46-173244. Fax: 46-46-189117. E-mail: gunnar.lindahl{at}mig.lu.se.


Infection and Immunity, December 1999, p. 6350-6357, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mavenyengwa, R. T., Maeland, J. A., Moyo, S. R. (2009). Putative Novel Surface-Exposed Streptococcus agalactiae Protein Frequently Expressed by the Group B Streptococcus from Zimbabwe. CVI 16: 1302-1308 [Abstract] [Full Text]  
  • Mavenyengwa, R. T., Maeland, J. A., Moyo, S. R. (2008). Distinctive Features of Surface-Anchored Proteins of Streptococcus agalactiae Strains from Zimbabwe Revealed by PCR and Dot Blotting. CVI 15: 1420-1424 [Abstract] [Full Text]  
  • Larsson, C, Lindroth, M, Nordin, P, Stalhammar-Carlemalm, M, Lindahl, G, Krantz, I (2006). Association between low concentrations of antibodies to protein {alpha} and Rib and invasive neonatal group B streptococcal infection.. Arch. Dis. Child. Fetal Neonatal Ed. 91: F403-F408 [Abstract] [Full Text]  
  • Seepersaud, R., Hanniffy, S. B., Mayne, P., Sizer, P., Le Page, R., Wells, J. M. (2005). Characterization of a Novel Leucine-Rich Repeat Protein Antigen from Group B Streptococci That Elicits Protective Immunity. Infect. Immun. 73: 1671-1683 [Abstract] [Full Text]  
  • Lindahl, G., Stalhammar-Carlemalm, M., Areschoug, T. (2005). Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens. Clin. Microbiol. Rev. 18: 102-127 [Abstract] [Full Text]  
  • Jarva, H., Hellwage, J., Jokiranta, T. S., Lehtinen, M. J., Zipfel, P. F., Meri, S. (2004). The Group B Streptococcal {beta} and Pneumococcal Hic Proteins Are Structurally Related Immune Evasion Molecules That Bind the Complement Inhibitor Factor H in an Analogous Fashion. J. Immunol. 172: 3111-3118 [Abstract] [Full Text]  
  • Larsson, C., Holmgren, J., Lindahl, G., Bergquist, C. (2004). Intranasal Immunization of Mice with Group B Streptococcal Protein Rib and Cholera Toxin B Subunit Confers Protection against Lethal Infection. Infect. Immun. 72: 1184-1187 [Abstract] [Full Text]  
  • MOYO, S. R., MAELAND, J. A., BERGH, K. (2002). Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J Med Microbiol 51: 595-662 [Abstract] [Full Text]  
  • Areschoug, T., Stalhammar-Carlemalm, M., Karlsson, I., Lindahl, G. (2002). Streptococcal beta Protein Has Separate Binding Sites for Human Factor H and IgA-Fc. J. Biol. Chem. 277: 12642-12648 [Abstract] [Full Text]  
  • Moyo, S. R., Maeland, J. A., Mudzori, J. (2001). Antibodies against Streptococcus agalactiae Proteins calpha and R4 in Sera from Pregnant Women from Norway and Zimbabwe. CVI 8: 1110-1114 [Abstract] [Full Text]  
  • Brodeur, B. R., Boyer, M., Charlebois, I., Hamel, J., Couture, F., Rioux, C. R., Martin, D. (2000). Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity. Infect. Immun. 68: 5610-5618 [Abstract] [Full Text]